期刊文献+

肾内科门诊高尿酸血症患者血尿酸达标率的横断面分析 被引量:2

Cross-sectional analysis of the control rate of hyperuricemia among outpatients in nephrology department
下载PDF
导出
摘要 目的探讨肾内科门诊高尿酸血症患者的治疗现状、血尿酸达标率及其影响因素。方法本研究为横断面分析,纳入2019年4月至2020年7月复旦大学附属中山医院肾内科门诊就诊的1499例高尿酸血症患者,比较不同临床特征患者的治疗方案及血尿酸控制情况,分析患者血尿酸达标率及其影响因素。结果1499例高尿酸血症患者,平均年龄(55.9±17.7)岁,估算肾小球滤过率(eGFR)小于60 mL/(min·1.73 m^(2))752例(50.2%)。1246例(83.1%)患者使用降尿酸药物治疗,30岁以下患者药物治疗率较低(P<0.01);相较于肾功能减退患者,肾功能正常患者药物治疗率较低(P<0.01)。患者平均血尿酸水平(431.5±118.3)μmol/L,血尿酸达标率46.4%,男性达标率为44.1%、女性为55.3%,差异有统计学意义(P<0.01)。相对于其他年龄组,30岁以下男性患者血尿酸达标率更低(P<0.01)。多因素logistic回归分析提示血尿酸控制与患者年龄、性别有关,男性(P<0.05)及30岁以下(P<0.01)患者血尿酸更不易达标。结论肾内科门诊就诊的高尿酸血症患者血尿酸达标率有待进一步提高,临床需重视年轻、男性患者尿酸水平管理和规范治疗。 Objective To explore the treatment status,control rate and influencing factors in outpatients with hyperuricemia in nephrology department.Methods 1499 outpatients of the Department of Nephrology,Zhongshan Hospital,Fudan University between April 2019 and July 2020 were included in this cross-sectional study.The treatment options and hyperuricemia control status of patients with different clinical characteristics were compared,influencing factors of compliance were analyzed.Results A total of 1499 patients with hyperuricemia were included,with an average age of(55.9±17.7)years old.The estimated glomerular filtration rate(eGFR)was less than 60 mL/(min·1.73 m^(2))in 752 cases(50.2%).1246 patients(83.1%)were treated with uric acid-lowering drugs with a significant lower rate in patients under 30 years old(P<0.01).The treatment rate of patients with normal renal function was significantly lower than that of patients with impaired renal function(P<0.01).The average serum uric acid level was(431.5±118.3)μmol/L.The whole control rate of hyperuricemia was 46.4%with 44.1%in men and 55.3%in women,the difference of which was statistically significant(P<0.01).Male patients under the age of 30 years old had lowest control rate compared with other age group(P<0.01).Multivariate logistic regression analysis indicated that male(P<0.05),age under 30 years old(P<0.01)were related factors to the control of hyperuricemia.Conclusions The control rate of hyperuricemia remains to be further improved in nephrology department,attention should be attached to the treatment and management of hyperuricemia in young male patients.
作者 张函 龚劭敏 沈子妍 余茜茜 陈静 王一梅 刘中华 章晓燕 丁小强 ZHANG Han;GONG Shao-min;SHEN Zi-yan;YU Xi-xi;CHEN Jing;WANG Yi-mei;LIU Zhong-hua;ZHANG Xiao-yan;DING Xiao-qiang(Department of Nephrology,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处 《中国临床医学》 2022年第2期140-146,共7页 Chinese Journal of Clinical Medicine
基金 国家自然科学基金(81903972) 上海市青年科技英才扬帆计划(19YF1406700)。
关键词 高尿酸血症 药物治疗 达标率 肾脏病 hyperuricemia drug treatment control rate kidney disease
  • 相关文献

参考文献5

二级参考文献38

  • 1邱强,陈香美,谢院生,魏日胞,吴镝,蔡广研,刘述文.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. 被引量:43
  • 2古萍.广州市体检人群高尿酸血症患病情况及相关疾病分析[J].中国热带医学,2006,6(6):1082-1084. 被引量:83
  • 3Khanna D, Fitzgerald JD, Khanna pp, et al. 2012 American college of rheumatology guidelines for management of gout: part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J]. Arthritis Care Res (Hoboken), 2012, 64: 1431-1446.
  • 4Hoskison TK, Wortmann RL. Advances in the management of gout and hyperuricaemia[J]. Scand J Rbeumatol, 2006, 35: 251- 260.
  • 5Pluim HJ, van Deuren M, Wetzels JF. The allopurinol hypersen?sitivity syndrome[J]. Neth J Med, 1998,52: 107-110.
  • 6Kim SC, Newcomb C, Margolis D, et al. Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study[J]. Arthritis Care Res (Hoboken), 2013, 65: 578-584.
  • 7Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review[J]. Crit Care Med , 2011, 39: 1521-1532.
  • 8Hung SI, Chung WH, Liou LB, et al. HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol[J]. Proc Natl Acad Sci USA, 2005, 102: 4134-4139.
  • 9Jung JW, Song WI. Kim YS, et al. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency[J]. Nephrol Dial Transplant, 2011, 26: 3567- 3572.
  • 10Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens?Johnson syndrome and toxic epidermal necrolysis[J]. Pharma?cogenomics, 2008, 9: 1617-1622.

共引文献1181

同被引文献47

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部